Renerva, LLC
Renerva Receives $2.4 Million DoD Award to Advance Its Peripheral Nerve Matrix Technology to the Clinic
12/14/18: Renerva's first product, peripheral nerve matrix (PNM), is an injectable gel derived from porcine tissue that promotes and supports repair and regeneration in injured peripheral nerves. The award will enable Renerva to complete its preclinical program and begin human clinical trials.
